JF
PVLA

Jump Financial’s Palvella Therapeutics PVLA Stock Holding History

Jump Financial’s Portfolio PVLA Stock Details PVLA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$6.02M Buy
39,413
+32,670
+485% +$3.97M 0.05% 440
2026
Q1 		$841K Buy
+6,743
New +$703K 0.01% 1001
2021
Q4 		– Sell
-1,098
Closed -$454K – 1783
2021
Q3 		$454K Buy
+1,098
New +$382K 0.03% 509

Other funds holding PVLA

SCM
Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $4.59B AUM 237.58% 1-Year Est. Return
FLAM
First Light Asset Management Edina, Minnesota $1.65B AUM 203.21% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
FCM
Frontier Capital Management Boston, Massachusetts $10.7B AUM 67.78% 1-Year Est. Return

Jump Financial's PVLA Position: Q2 2026 in Review

Jump Financial increased its Palvella Therapeutics (PVLA) stake by 485% in Q2 2026, buying an estimated $3.97M and bringing the position to 39,413 shares worth $6.02M. The position accounts for 0.05% of the portfolio, ranked #440.

Jump Financial first reported a position in PVLA in Q3 2021 and has held it in 3 quarters since. 196 funds tracked by Wall St. Rank hold PVLA as of Q2 2026.

  • Jump Financial held 39,413 shares of Palvella Therapeutics worth $6.02M as of Q2 2026.
  • Jump Financial bought 32,670 Palvella Therapeutics shares in Q2 2026, an estimated $3.97M.
  • Palvella Therapeutics made up 0.05% of Jump Financial's portfolio in Q2 2026, its #440 holding.
  • Jump Financial first reported a position in Palvella Therapeutics in Q3 2021 and has held it in 3 quarters since.
  • 196 funds tracked by Wall St. Rank held Palvella Therapeutics as of Q2 2026.

Based on Jump Financial's 13F filing for Q2 2026, filed 13 Aug 2026.